HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lipoxin A4

an antifibrolytic agent; structure given in first source; a role in ASPIRIN antiinflammatory activity
Also Known As:
15-epi-LXA4; 15-epi-lipoxin A4; 5,6,15-tri-HETE; 5,6,15-triHETE; 5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid; LXA4
Networked: 242 relevant articles (25 outcomes, 32 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Levy, Bruce D: 12 articles (08/2015 - 10/2005)
2. Serhan, Charles N: 10 articles (07/2015 - 01/2002)
3. Ye, Duyun: 9 articles (08/2015 - 01/2009)
4. Wu, Ping: 8 articles (08/2015 - 02/2007)
5. Wu, Sheng-Hua: 8 articles (07/2015 - 06/2006)
6. Godson, Catherine: 7 articles (07/2015 - 08/2003)
7. Das, Undurti N: 6 articles (02/2015 - 01/2011)
8. Serhan, C N: 6 articles (01/2015 - 01/2000)
9. Israel, Elliot: 6 articles (10/2014 - 10/2005)
10. Gronert, Karsten: 5 articles (10/2015 - 09/2005)

Related Diseases

1. Inflammation
2. Reperfusion Injury
3. Sepsis (Septicemia)
4. Lung Injury
5. Myocardial Ischemia (Ischemic Heart Diseases)

Related Drugs and Biologics

1. lipoxin A4
2. Lipoxins
3. Aspirin (Acetylsalicylic Acid)
4. Interleukin-6 (Interleukin 6)
5. Heme Oxygenase-1
6. Carrageenan
7. Urocanic Acid
8. Anti-Bacterial Agents (Antibiotics)
9. p38 Mitogen-Activated Protein Kinases
10. Toll-Like Receptors (Toll-Like Receptor)

Related Therapies and Procedures

1. Intravitreal Injections
2. Ligation
3. Spinal Injections
4. Immunomodulation
5. Intravenous Injections